about
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cellsSelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerHighly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.Plasticity of γδ T Cells: Impact on the Anti-Tumor ResponseEctopic expression of human MutS homologue 2 on renal carcinoma cells is induced by oxidative stress with interleukin-18 promotion via p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) signaling pathways.Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.Overview of the progress on haploidentical hematopoietic transplantation.Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.The role of CCN family genes in haematological malignancies.The PPARα pathway in Vγ9Vδ2 T cell anergy.Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells.A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.Inhibition of phosphoantigen-mediated gammadelta T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells.Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors.Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.Atypical cutaneous γδ T cell proliferation with morphologic features of lymphoma but with clinical features and course of PLEVA or lymphomatoid papulosis.Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity.Adoptive cell therapy against EBV-related malignancies: a survey of clinical results
P2860
Q21245481-AEB4BB5F-9937-44B8-A14A-F49738CCC327Q28287583-A8F67D93-EDA0-4250-8419-05A149F6804BQ28659468-47EEF256-54F0-481C-B378-8F149C65CABEQ33455830-BD117236-C31A-4F01-99F9-7AC075BD796DQ33747619-10C4FD98-1923-4CCB-910E-D513FD3C9A7AQ34652408-29D18C1A-F295-45DC-B467-89D840CF73AEQ36003744-7E1AA047-E807-4D3B-93EF-5859FA9344F6Q37038276-81760EBA-85BF-4018-A18C-EC59BA267DBEQ37522577-9CA1A773-5F8E-4AD8-B120-45E96CA1E702Q37731978-E1607F8C-D3FF-409B-B55F-88B86A205527Q37876363-E8A8EE13-BA85-46DD-80E5-7BEEB777925BQ38051222-461298A7-94DC-4AC1-8F6D-31819325CD14Q38508845-63563108-4911-4AEC-AAD5-96DFDA30BB53Q38937755-707489A9-5814-4285-A13C-2ECF643999BCQ39729244-5BF69283-FFCB-4437-96FC-E3D08550AFA9Q45325513-64F2C0E1-1CC6-459C-A66A-7F222B2CE0C9Q46131239-9E4A2B2B-9D42-437A-BDE9-1EDB45D2E983Q46385904-08DBD718-44FA-40B8-90A3-D1F9377E4CD5Q50555866-96D3DEA8-6EAB-48D4-ABA4-D290D2353D11Q52649705-DD44EF56-9E54-4931-843F-9C179D149055Q53721205-A1F216F0-D3DC-4AD8-BFDB-76B45E979CF1Q53764518-BE35A53D-60F8-4E31-848C-F8E9C7CB06B4Q55285823-37A86D90-806B-420B-A899-A276230D5617Q57056125-6B0DDA41-8205-47FF-8830-F843C7F5689A
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Anti-lymphoma effect of gammadelta T cells.
@ast
Anti-lymphoma effect of gammadelta T cells.
@en
type
label
Anti-lymphoma effect of gammadelta T cells.
@ast
Anti-lymphoma effect of gammadelta T cells.
@en
prefLabel
Anti-lymphoma effect of gammadelta T cells.
@ast
Anti-lymphoma effect of gammadelta T cells.
@en
P2860
P1433
P1476
Anti-lymphoma effect of gammadelta T cells.
@en
P2093
Martin Wilhelm
Volker Kunzmann
P2860
P304
P356
10.1080/10428190500051893
P577
2005-05-01T00:00:00Z